Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 8:01 p.m.

    📋 Acumen Pharmaceuticals Inc (ABOS) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 08:33:26

    Event Type: Clinical Trial Update

    Event Details:

    Acumen Pharmaceuticals Inc (ABOS) Announces Clinical Trial Update Acumen Pharmaceuticals Inc (ABOS) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: EBD
      • expected in late 2026
      • expected in early 2026
      • Expected in Late 2026

    🔬 Clinical Development Pipeline (Acumen Pharmaceuticals Inc):

    Product Type Development Stage Therapeutic Area Source
    sabirnetug DRUG Phase PHASE2 Alzheimer Disease ClinicalTrials.gov
    ACU193 DRUG Phase PHASE1 Alzheimer Disease ClinicalTrials.gov
    sabirnetug (ACU193) DRUG Phase PHASE1 Alzheimer Disease ClinicalTrials.gov
    Placebo DRUG Phase PHASE2 Alzheimer Disease ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Acumen Pharmaceuticals Inc
    • Ticker Symbol: ABOS

Search

News categories